What is it all about?

South Korea is one of the emerging global markets for pharmaceutical products, valued at $27.9 billion in 2020, and is expected to grow at a CAGR of 4.4%, reaching $35.1 billion by 2030. Managing pharmaceutical license transfers in South Korea requires meticulous planning, comprehensive documentation, and strict adherence to MFDS guidelines. Efficient license transfer management is crucial for sustaining industry growth and public health.

Are you looking for support with license transfers or want to manage them effectively in South Korea? Attend our webinar to learn successful strategies for navigating this intricate process.

The webinar will be hosted by Michael Lambell- Sr. Vice President MPR Regulatory Affairs, and presented by Kyeomju Nah, Senior Manager MPR Regulatory Affairs – South Korea.

In brief, the topics to be discussed during the webinar include: 

• Defining the process and importance of license transfer in the pharmaceutical industry.
• Discussing successful strategies for managing license transfers effectively.
• Highlighting Regulatory considerations and requirements during license transfers.
• Question & Answers (Q&A). 

With respect to your busy schedule, we really look forward to seeing you in the webinar. Stay safe.